Epsilon Historical Cash Flow

EPN Stock

0.02 0.00 0.00%

Analysis of Epsilon Healthcare cash flow over time is an excellent tool to project Epsilon Healthcare future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 790.5 K or Total Cash From Financing Activities of 1.4 M as it is a great indicator of Epsilon Healthcare ability to facilitate future growth, repay debt on time or pay out dividends.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Epsilon Healthcare latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Epsilon Healthcare is a good buy for the upcoming year.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Epsilon Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Epsilon Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Epsilon balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Epsilon's non-liquid assets can be easily converted into cash.

Epsilon Healthcare Cash Flow Chart

At this time, Epsilon Healthcare's Sale Purchase Of Stock is comparatively stable compared to the past year. Other Cashflows From Financing Activities is likely to gain to about 1.9 M in 2024, whereas Total Cash From Operating Activities is likely to drop (2.4 M) in 2024.

Sale Purchase Of Stock Total Cashflows From Investing Activities End Period Cash Flow Investments Begin Period Cash Flow Other Non Cash Items

Total Cashflows From Investing Activities

The net amount of cash used in or generated from a company's investment activities, such as purchasing or selling assets, during a reporting period.

Investments

Securities or assets acquired for generating income or appreciating in value, not used in daily operations.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Most accounts from Epsilon Healthcare's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Epsilon Healthcare current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Epsilon Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2020	2021	2023	2024 (projected)
Stock Based Compensation	7.3K	1.1M	984.7K	600.5K
Issuance Of Capital Stock	10.6M	2.4M	2.8M	2.7M

Stock Based Compensation Issuance Of Capital Stock

Epsilon Healthcare cash flow statement Correlations

	Sale Purchase Of Stock	Change In Cash	End Period Cash Flow	Change To Inventory	Investments	Net Borrowings	Free Cash Flow	Change In Working Capital	Begin Period Cash Flow	Depreciation	Change To Account Receivables	Net Income	Change To Netincome	Change To Liabilities	Issuance Of Capital Stock	Stock Based Compensation	Other Non Cash Items	Dividends Paid
Sale Purchase Of Stock		0.62	0.92	0.0	-0.28	0.28	-0.37	-0.03	0.14	0.18	-0.3	-0.21	-0.03	0.16	0.47	-0.49	-0.17	-0.03
Change In Cash	0.62		0.51	-0.3	0.37	0.45	0.42	-0.16	-0.64	-0.26	0.35	0.5	-0.46	0.64	0.37	-0.14	-0.08	0.16
End Period Cash Flow	0.92	0.51		-0.25	-0.47	0.41	-0.43	-0.29	0.32	-0.11	-0.1	-0.05	-0.22	0.12	0.44	-0.26	-0.29	0.23
Change To Inventory	0.0	-0.3	-0.25		-0.02	-0.76	-0.08	0.97	0.11	0.86	-0.58	-0.76	0.96	-0.71	-0.4	-0.24	0.74	-0.78
Investments	-0.28	0.37	-0.47	-0.02		-0.21	0.79	0.07	-0.83	-0.13	0.3	0.41	-0.11	0.38	-0.35	0.34	0.15	-0.03
Net Borrowings	0.28	0.45	0.41	-0.76	-0.21		-0.15	-0.69	-0.13	-0.6	0.35	0.5	-0.83	0.78	0.83	-0.25	-0.54	0.56
Free Cash Flow	-0.37	0.42	-0.43	-0.08	0.79	-0.15		0.1	-0.83	-0.33	0.69	0.68	-0.22	0.26	-0.44	0.51	0.25	-0.03
Change In Working Capital	-0.03	-0.16	-0.29	0.97	0.07	-0.69	0.1		-0.07	0.78	-0.42	-0.6	0.88	-0.62	-0.38	-0.21	0.81	-0.78
Begin Period Cash Flow	0.14	-0.64	0.32	0.11	-0.83	-0.13	-0.83	-0.07		0.19	-0.43	-0.57	0.31	-0.6	-0.02	-0.11	-0.22	-0.07
Depreciation	0.18	-0.26	-0.11	0.86	-0.13	-0.6	-0.33	0.78	0.19		-0.86	-0.84	0.85	-0.5	-0.07	-0.59	0.44	-0.68
Change To Account Receivables	-0.3	0.35	-0.1	-0.58	0.3	0.35	0.69	-0.42	-0.43	-0.86		0.91	-0.65	0.34	-0.18	0.66	-0.1	0.37
Net Income	-0.21	0.5	-0.05	-0.76	0.41	0.5	0.68	-0.6	-0.57	-0.84	0.91		-0.84	0.65	0.05	0.46	-0.34	0.49
Change To Netincome	-0.03	-0.46	-0.22	0.96	-0.11	-0.83	-0.22	0.88	0.31	0.85	-0.65	-0.84		-0.82	-0.48	-0.17	0.65	-0.75
Change To Liabilities	0.16	0.64	0.12	-0.71	0.38	0.78	0.26	-0.62	-0.6	-0.5	0.34	0.65	-0.82		0.65	-0.2	-0.5	0.49
Issuance Of Capital Stock	0.47	0.37	0.44	-0.4	-0.35	0.83	-0.44	-0.38	-0.02	-0.07	-0.18	0.05	-0.48	0.65		-0.71	-0.42	0.3
Stock Based Compensation	-0.49	-0.14	-0.26	-0.24	0.34	-0.25	0.51	-0.21	-0.11	-0.59	0.66	0.46	-0.17	-0.2	-0.71		0.17	0.35
Other Non Cash Items	-0.17	-0.08	-0.29	0.74	0.15	-0.54	0.25	0.81	-0.22	0.44	-0.1	-0.34	0.65	-0.5	-0.42	0.17		-0.4
Dividends Paid	-0.03	0.16	0.23	-0.78	-0.03	0.56	-0.03	-0.78	-0.07	-0.68	0.37	0.49	-0.75	0.49	0.3	0.35	-0.4

Click cells to compare fundamentals

Epsilon Healthcare Account Relationship Matchups

Epsilon Healthcare cash flow statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Sale Purchase Of Stock	4.5M	10.8M	2.5M	2.9M	2.6M	4.6M
Change In Cash	(2.8M)	3.4M	(4.6M)	(1.5M)	(1.3M)	(1.3M)
Total Cashflows From Investing Activities	(714.7K)	(1.7M)	(737.6K)	(529.4K)	(608.8K)	(639.3K)
Other Cashflows From Financing Activities	(714.7K)	(559.0K)	(929.7K)	1.6M	1.8M	1.9M
Capital Expenditures	714.7K	1.2M	747.7K	529.4K	476.5K	790.5K
Total Cash From Operating Activities	(7.9M)	(8.7M)	(5.4M)	(2.6M)	(2.3M)	(2.4M)
Total Cash From Financing Activities	5.8M	14.6M	1.5M	1.6M	1.4M	1.4M
End Period Cash Flow	3.6M	7.0M	2.3M	862.0K	775.8K	737.0K
Change To Inventory	(6.3K)	(386.1K)	(456.6K)	2.4M	2.8M	2.9M
Investments	(714.7K)	(1.7M)	(737.6K)	(529.4K)	(608.8K)	(639.3K)
Free Cash Flow	(8.6M)	(9.9M)	(6.2M)	(3.1M)	(2.8M)	(2.9M)
Change In Working Capital	(147.2K)	(119.9K)	(988.4K)	3.2M	3.7M	3.9M
Begin Period Cash Flow	6.3M	3.6M	7.0M	2.3M	2.1M	4.1M
Depreciation	222.1K	1.6M	1.1M	1.9M	2.1M	2.2M
Change To Account Receivables	(668.9K)	(1.1M)	(843.7K)	(795.2K)	(715.6K)	(751.4K)
Net Income	(11.7M)	(10.5M)	(9.2M)	(13.3M)	(12.0M)	(12.6M)
Change To Netincome	3.9M	395.2K	3.7M	8.2M	9.5M	10.0M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Epsilon Stock Analysis

When running Epsilon Healthcare's price analysis, check to measure Epsilon Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Epsilon Healthcare is operating at the current time. Most of Epsilon Healthcare's value examination focuses on studying past and present price action to predict the probability of Epsilon Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Epsilon Healthcare's price. Additionally, you may evaluate how the addition of Epsilon Healthcare to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC